CorMatrix Cardiovascular is seeking $25 million in an equity offering.
The Roswell, Ga.-based medical device company makes cardiovascular devices designed to treat damaged heart tissue. The CorMatrix flagship product is a biomaterial implant designed to help the heart heal itself.
CorMatrix set a minimum investment of $250,000, so far attracting 1 investor, according to a regulatory filing.